14-CpG-Based Signature Improves the Prognosis Prediction of Hepatocellular Carcinoma Patients

Figure 2

Selection of key prognosis-associated CpGs. (a) Overlap of each of the top 1000 differential CpGs from GSE73003, GSE37988, and GSE57958; (b) and (c) 21 prognosis-associated CpGs were identified by LASSO analysis in the development cohort; (d) 14 overlap CpGs were selected by robust likelihood-based survival analysis and LASSO analysis in the development cohort.

(a)

(b)

(c)

(d)